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Case Report
INTRODUCTION
The cause of acquired facial nerve palsy (FNP) in the pediatric population can be classified as infectious, traumatic, malignancy 
associated, hypertension associated, and idiopathic (Bell’s palsy) (Table 1). Toddlers and preteenagers may be at higher risk for FNP 
because of infectious and traumatic causes [1].
The main pathogens causing FNP in children are Borrelia burgdorferi (50%), idiopatic or Bell’s palsy (26%), otitis media (OM) (12%), 
varicella-zoster virus (6%), Herpes simplex virus (4%), and coxsackie (2%) [2]. A thorough research of the literature showed that al-
though rare, Epstein–Barr virus (EBV) can also be linked to FNP [3, 4]. Here we present the case of two brothers with an EBV-derived 
unilateral FNP.
CASE PRESENTATION
A 7-month-old boy (patient A) without previous otologic history was referred to our Ear Nose Throat tertiary referral center for the 
evaluation of a left-sided unilateral FNP that developed after 2 days of fever. A ventilation tube (VT) was placed in the referring 
hospital 2 days earlier because of signs of OM with effusion. On examination in our hospital 4 days after onset, House–Brackmann 
(HB) [5] score grade IV (Table 2), hepatosplenomegaly, and bilateral enlarged cervical glands were observed. Otoscopy showed VT 
with clear otorrhea, without clinical signs of mastoiditis. A polymerase chain reaction (PCR) on EBV was conducted and confirmed 
an acute EBV infection.
Contrast-enhanced computed tomographic (cCT) scan (Aquilion ONE ViSION Edition; Toshiba Medical Systems, Otawara, Japan) 
demonstrated opacification of the mastoid and middle ear as seen in otomastoiditis. Contrast-enhanced magnetic resonance im-
aging (cMRI) scan (Siemens Avanto 1,5T, Erlangen, Germany) demonstrated otitis media and mastoiditis, particularly around the 
apex pars petrosae, with signs of abscess formation. From the day of onset, the patient was pharmacologically treated for 2 days 
with azithromycin (Zithromax by Pfizer BV, New York City, United States of America), followed by 2 days of ceftriaxone and simul-
taneously for 7 days with eardrops consisting hydrocortisone, colistin, and bacitracin (Bacicoline-B by Daleco Pharma BV, Enspijk, 
The Netherlands).
Based on the diagnosis of EBV-induced mastoiditis complicated by FNP that did not improve with antibiotic treatment, mastoid-
ectomy and atticoantrotomy were performed 6 days after onset of FNP. Granulation tissue from the mastoid was positive for EBV. 
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After the surgical treatment, patient A clinically recovered to a HB II, 
with minimal asymmetry and eye closure after 1 month, and HB I 6 
months later.
Two months later, his brother (patient B), aged 2 years and 8 months, 
showed a left-sided unilateral FNP grade V HB. FNP was preceded by 
2 days of otalgia and fever. A secondary referral center placed a VT 
that showed thickened mucosa without signs of acute OM. He only 
had a medical history of adenotonsillectomy because of obstructive 
sleep apnea syndrome.
Polymerase chain reaction on EBV that was conducted consider-
ing the disease course of his brother indicated an acute EBV in-
fection. cCT showed otomastoiditis, with complete opacification 
of the mastoid and middle ear. cMRI showed slight coloration of 
the geniculate ganglion on the tympanal and mastoidal part of the 
facial nerve (Figure 1). Otoacoustic emissiontest reported bilateral 
normal inducible emissions. Two EMGs 14 and 37 days after onset 
found a severe neuropathy with a non-inducible musculus orbicu-
laris oculi and musculus nasalis. Over 90% difference in compound 
muscle action potential (CMAP) amplitude was found in relation to 
the right side.
The patient was initially pharmacologically treated for 5 days with 
amoxicillin/clavulanic acid. After PCR on EBV was positive, treatment 
was switched to 5 days ceftriaxone. During the same period, he was 
treated with glucocorticoids and eardrops consisting hydrocorti-
sone, colistin, and bacitracin (Bacicoline-B by Daleco Pharma BV, En-
spijk, The Netherlands).
After 6 weeks, no improvement of FNP was seen, and transmastoidal 
surgical decompression of the facial nerve from geniculate ganglion to 
the stylomastoid foramen was performed. During surgery, a pale white 
facial nerve was observed that regained vascularization after decom-
pression (Video 1. See corresponding video/movie images at http://
www.advanceotology.org). The postoperative course was complicated 
by a bacterial mastoiditis that needed surgery. After the second sur-
gery, Patient B recovered to a HB III in 3 weeks and HB II after 6 months, 
with movement and only slight asymmetry of the mouth. We obtained 
written informed consent from the parents of the brothers.
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Table 1. Causes of facial nerve palsy in children [1, 3]
Genetic  Fascioscapulohumeral dystrophy
 Myotonic dystrophy
 Myasthenic syndromes 
Congenital  Arnold Chiari syndrome
 Cardiofacial syndrome
 Facial nerve malformations
Trauma Birth trauma
 Temporal bone fracture
 Increased intracranial pressure
 Iatrogenic trauma
Infectious  Lyme disease
 Herpes simplex virus
 Varicella virus
 Otitis media and mastoiditis
 Tuberculosis
 Parotitis
 Mycoplasma pneumoniae infection
 Guillain–Barré syndrome
 Epstein–Barr infection
 Ramsay Hunt syndrome
 Miller Fisher syndrome
 Vasculitis
 Sarcoidosis 
Neoplasms  Brain stem glioma
 Parotid tumor
 Leukemia
Metabolic  Diabetes mellitus
 Hyperparathyroidism
 Hypothyroidism
Other  Hypertension-associated hemophilia
Idiopathic Bell’s palsy
Table 2. The House–Brackmann Facial Nerve Grading Scale [5]
Grade  Description Characteristics
I Normal Normal facial function in all areas
II  Slight Appearance: Slight weakness noticeable  
   on close inspection; may  
   have very slight synkinesis
  At rest: Normal symmetry and tone
  Forehead motion: Moderate-to-good function
  Eyelid closure: Complete with minimal effort
  Mouth motion: Slight asymmetry
III Moderate Appearance: Obvious but not disfiguring  
   weakness between the two  
   sides; noticeable but not  
   severe synkinesis, contracture,  
   and/or hemifacial spasm
  At rest: Normal symmetry and tone
  Forehead motion: Slight-to-moderate movement
  Eyelid closure: Complete with effort
  Mouth motion: Slightly weak with maximal effort
IV Moderate- Appearance: Obvious weakness and/or 
 severe   disfiguring asymmetry 
 dysfunction  
  At rest: Normal symmetry and tone
  Forehead motion: None
  Eyelid closure: Incomplete
  Mouth motion: Asymmetric with maximal effort
V Severe Appearance: Only barely perceptible motion
  At rest: Asymmetric
  Forehead motion: None
  Eyelid closure: Incomplete
  Mouth motion: Slight movement
VI Total  No facial function
DISCUSSION
Epstein-Barr virus is a relatively unknown cause of FNP; it is inciden-
tally reported, and case reports focus on diagnosis rather than treat-
ment. Consequently, literature on treatment of EBV-induced FNP is 
inconclusive and mainly based on expert opinions. Choosing the most 
appropriate treatment should be guided by etiology and severity of 
FNP. Each patient needs an individual approach based on the patient’s 
condition, duration and cause of paralysis, physical finding, EMG, au-
diogram, anatomical status of the facial nerve, and expectations [6].
A conservative approach, potentially supplemented with EMG fol-
low-up, could be indicated if the facial nerve is anatomically intact 
and EMG shows less than a 90% difference in CMAP. Recovery of an 
infection-derived FNP usually takes less than 1 month. Nearly always 
substantial (HB II) to complete (HB I) recovery is attained [1]. In other 
EBV-associated neurological complications, the prognosis is good; 
therefore, intervention is not ushered. This could also be the case for 
EBV-associated FNP [6].
Pharmacological treatment can be performed using corticosteroids, 
antibiotics, or antiviral medication. Inflammation and associated ede-
ma are considered to be one of causes of FNP. Reducing this edema 
with corticosteroids accelerates spontaneous clinical improvement 
of FNP. Controversy remains on the benefit of steroid treatment use 
in children as clear studies are not available [7]. If a bacterial infection, 
such as OM, is the cause of FNP, antibiotics should be administered. 
OM-associated FNP is less prevalent since the antibiotic era. In the 
pre-antibiotic era 0.5%–0.7% of OM were complicated by FNP be-
cause of persistent inflammation of the fallopian canal. Currently, this 
complication has become exceptional with an incidence of 0.005% [8]. 
When FNP is caused by EBV, treatment with antiviral therapy is ques-
tionable. A meta-analysis showed no clinical benefit comparing the 
treatment of EBV infections with acyclovir and placebo treatment [9].
Surgical intervention could be indicated when a conservative or 
pharmacological approach is not sufficient. The rapid improved vas-
cularization of the facial nerve after decompression suggests that a 
decreased vascular perfusion might be an important factor in the 
pathogenesis of FNP; therefore, surgical decompression is necessary 
[10]. As a guide to determine when decompression is warranted, EMG 
measurements can be used. Patients with less than 90% reduction 
are likely to return to a HB grade I or II. If patients have more than 90% 
reduction of CMAP within 14 days, they are likely to have a HB grade 
III or IV. In this case, surgical decompression provided significant im-
provement to normal or near-normal recovery. The best results in pa-
tients with Bell’s palsy with more than 90% reduction in CMAP within 
14 days of onset were achieved if surgery was performed within 2 or 
3 weeks after onset of FNP [11].
There are different surgical approaches to establish facial nerve de-
compression. The different approaches are based on multiple surgical 
techniques, such as the transmastoid approach reaching the tympanic 
and mastoid segments and the geniculate ganglion. The middle fossa 
approach can be added to reach the labyrinthine segment [7].
The most suitable treatment for the pediatric population with an EBV-de-
rived FNP is still unknown. In our cases, the question remains whether 
surgical treatment or natural course caused the clinical improvement of 
FNP. Larger studies comparing the different treatments of FNP with the 
natural course are needed in order to provide a clear answer.
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Video 1. Facial nerve decompression.
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